213 related articles for article (PubMed ID: 2463620)
1. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.
Noda M; Kitayama H; Matsuzaki T; Sugimoto Y; Okayama H; Bassin RH; Ikawa Y
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):162-6. PubMed ID: 2463620
[TBL] [Abstract][Full Text] [Related]
2. Detection of genes with potential of suppressing transforming activity of the v-Ki-ras oncogene.
Noda M; Ikawa Y
Princess Takamatsu Symp; 1986; 17():261-7. PubMed ID: 3332014
[TBL] [Abstract][Full Text] [Related]
3. Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.
Noda M; Selinger Z; Scolnick EM; Bassin RH
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5602-6. PubMed ID: 6604274
[TBL] [Abstract][Full Text] [Related]
4. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
Radinsky R; Culp LA
Int J Cancer; 1991 Apr; 48(1):148-59. PubMed ID: 2019453
[TBL] [Abstract][Full Text] [Related]
5. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
6. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
[TBL] [Abstract][Full Text] [Related]
7. A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.
Kato J; Sherr CJ
Oncogene; 1991 May; 6(5):687-93. PubMed ID: 2052353
[TBL] [Abstract][Full Text] [Related]
8. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
9. Permanent conversion of mouse and human cells transformed by activated ras or raf genes to apparently normal cells by treatment with the antibiotic azatyrosine.
Shindo-Okada N; Makabe O; Nagahara H; Nishimura S
Mol Carcinog; 1989; 2(3):159-67. PubMed ID: 2675904
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of an infinite life span human fibroblast cell strain by transfection with v-Ki-ras.
Fry DG; Milam LD; Dillberger JE; Maher VM; McCormick JJ
Oncogene; 1990 Sep; 5(9):1415-8. PubMed ID: 2216465
[TBL] [Abstract][Full Text] [Related]
11. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
[TBL] [Abstract][Full Text] [Related]
12. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
Sugimoto Y; Ikawa Y; Nakauchi H
Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
[TBL] [Abstract][Full Text] [Related]
13. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.
Paterson H; Reeves B; Brown R; Hall A; Furth M; Bos J; Jones P; Marshall C
Cell; 1987 Dec; 51(5):803-12. PubMed ID: 3315232
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells.
Colletta G; Cirafici AM; Di Carlo A; Ciardiello F; Salomon DS; Vecchio G
Oncogene; 1991 Apr; 6(4):583-7. PubMed ID: 1709483
[TBL] [Abstract][Full Text] [Related]
15. A ras-related gene with transformation suppressor activity.
Kitayama H; Sugimoto Y; Matsuzaki T; Ikawa Y; Noda M
Cell; 1989 Jan; 56(1):77-84. PubMed ID: 2642744
[TBL] [Abstract][Full Text] [Related]
16. Elevated gelsolin and alpha-actin expression in a flat revertant R1 of Ha-ras oncogene-transformed NIH/3T3 cells.
Müllauer L; Fujita H; Suzuki H; Katabami M; Hitomi Y; Ogiso Y; Kuzumaki N
Biochem Biophys Res Commun; 1990 Sep; 171(2):852-9. PubMed ID: 2169737
[TBL] [Abstract][Full Text] [Related]
17. Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.
Norton JD; Cook F; Roberts PC; Clewley JP; Avery RJ
J Virol; 1984 May; 50(2):439-44. PubMed ID: 6323744
[TBL] [Abstract][Full Text] [Related]
18. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
[TBL] [Abstract][Full Text] [Related]
19. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes.
Spandidos DA; Frame M; Wilkie NM
Anticancer Res; 1990; 10(6):1543-54. PubMed ID: 2285227
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
Mello ML; Contente S; Vidal BC; Planding W; Schenck U
Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
